Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...